Literature DB >> 22090092

[Prophylaxis and therapy of postoperative endophthalmitis. Criticism of the ESCRS study and the Early Vitrectomy study].

W Behrens-Baumann1.   

Abstract

Postoperative endophthalmitis often leads to a substantial loss of vision and sometimes to loss of the eye. Occasionally this results in legal disputes during which medical studies will be consulted for reaching a verdict. Both the European Society of Cataract and Refractive Surgeons (ESCRS) study on prophylaxis and the Early Vitrectomy study on the therapy of postoperative endophthalmitis suffer from substantial deficits in essential areas. These studies cannot therefore be utilized as standard operating procedures and guidelines as well as in legal disputes.

Entities:  

Mesh:

Year:  2011        PMID: 22090092     DOI: 10.1007/s00347-011-2456-0

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  45 in total

Review 1.  Management of endophthalmitis in the post-endophthalmitis vitrectomy study era.

Authors:  P Sternberg; D F Martin
Journal:  Arch Ophthalmol       Date:  2001-05

2.  ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Preliminary report of principal results from a European multicenter study.

Authors:  Peter Barry; David V Seal; George Gettinby; Fiona Lees; Magnus Peterson; Crawford W Revie
Journal:  J Cataract Refract Surg       Date:  2006-03       Impact factor: 3.351

Review 3.  [Surgical prophylaxis for postoperative endophthalmitis following phakoemulsification. A short review].

Authors:  W Behrens-Baumann
Journal:  Klin Monbl Augenheilkd       Date:  2008-11-17       Impact factor: 0.700

Review 4.  Postoperative endophthalmitis.

Authors:  Nick Mamalis; Laura Kearsley; Eric Brinton
Journal:  Curr Opin Ophthalmol       Date:  2002-02       Impact factor: 3.761

5.  Risk of endophthalmitis after cataract extraction: results from the International Cataract Surgery Outcomes study.

Authors:  J C Norregaard; H Thoning; P Bernth-Petersen; T F Andersen; J C Javitt; G F Anderson
Journal:  Br J Ophthalmol       Date:  1997-02       Impact factor: 4.638

6.  Comparison of the effect of intracameral moxifloxacin, levofloxacin and cefazolin on rabbit corneal endothelial cells.

Authors:  Su-Young Kim; Young-Hoon Park; Young-Chun Lee
Journal:  Clin Exp Ophthalmol       Date:  2008-05       Impact factor: 4.207

Review 7.  Perspectives on antibiotics for postoperative endophthalmitis prophylaxis: potential role of moxifloxacin.

Authors:  Terrence P O'Brien; Steve A Arshinoff; Francis S Mah
Journal:  J Cataract Refract Surg       Date:  2007-10       Impact factor: 3.351

8.  Postoperative endophthalmitis associated with sutured versus unsutured clear corneal cataract incisions.

Authors:  Susan S Thoms; David C Musch; H Kaz Soong
Journal:  Br J Ophthalmol       Date:  2007-06       Impact factor: 4.638

9.  Comparison of in vitro safety profiles of vancomycin and cefuroxime on human corneal endothelial cells for intracameral use.

Authors:  Efdal Yoeruek; Martin S Spitzer; Oguzhan Saygili; Olcay Tatar; Tilo Biedermann; Erdal Yoeruek; Karl U Bartz-Schmidt; Peter Szurman
Journal:  J Cataract Refract Surg       Date:  2008-12       Impact factor: 3.351

10.  Prophylactic intracameral cefazolin after cataract surgery: endophthalmitis risk reduction and safety results in a 6-year study.

Authors:  Magela Garat; Carlos L Moser; Montserrat Martín-Baranera; Carles Alonso-Tarrés; Luis Alvarez-Rubio
Journal:  J Cataract Refract Surg       Date:  2009-04       Impact factor: 3.351

View more
  3 in total

1.  [Intraocular lens as a drug delivery device].

Authors:  K H Eibl-Lindner; R Liegl; C Wertheimer; A Kampik
Journal:  Ophthalmologe       Date:  2013-10       Impact factor: 1.059

Review 2.  [VEGF inhibitors in vitreoretinal interventions].

Authors:  N Feltgen; A Stahl
Journal:  Ophthalmologe       Date:  2013-10       Impact factor: 1.059

3.  Recurrent endophthalmitis after trabeculectomy for glaucoma: importance of timely filtering bleb coverage for the conjunctiva.

Authors:  Carl-Ludwig Schönfeld
Journal:  Case Rep Ophthalmol       Date:  2012-10-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.